There has been increasing concern that the UK may withdraw from the EU without concluding a withdrawal agreement under Article 50 of the Treaty on European Union and without any transition (or implementation) period to allow market participants time to adjust.
There has been considerable discussion of the impact of this ‘no deal’ scenario on the ability of UK firms to rely on their single market passports, both to conduct new over-the-counter (OTC) derivatives business and to service legacy contracts with EU 27 clients and counterparties without authorization in the EU 27 (as well as on the obstacles to UK firms transferring legacy contracts to EU 27 affiliates). Similarly, there has been discussion of the corresponding impact of the loss of the passport on EU 27 firms conducting OTC derivatives business with UK clients and counterparties. This paper does not discuss those issues.
Instead, this paper sets out other reasons why a ‘no deal’ scenario has the potential to create a disruptive cliff-edge change in the EU regulatory requirements that apply to OTC derivatives business in a way that may adversely affect EU 27 or UK firms and their EU 27 and UK clients and counterparties.
This paper focuses on the treatment of OTC derivatives business under existing EU law. It does not consider the impact of any current legislative proposals to amend that law or whether any such amendments are likely to take effect in advance of Brexit. This paper does not address any issues arising under data protection legislation or consumer law.
The paper was developed by the International Swaps and Derivatives Association, the Association of German Banks (Bundesverband deutscher Banken), the Italian Financial Markets Intermediaries Association (Associazione Intermediari Mercati Finanziari, or ASSOSIM), the Banking and Payments Federation Ireland, the Danish Securities Dealers Association (Børsmæglerforening Danmark), the Dutch Banking Association (Nederlandse Vereniging van Banken) and the Swedish Securities Dealers Association (Svenska Fondhandlareföreningen).
Click on the attached PDF to read the full paper.
Documents (1) for Cliff Edge Effects under EU Law in a No Deal Brexit Scenario
Latest
Determining Initial Reference Index for New Trades
On November 25, 2025, ISDA published a Market Practice Note (MPN) to recommend a specific methodology that market participants could elect to use for the purposes of determining the Initial Reference Index for certain new inflation derivative transactions given that...
ISDA Response to FCA on Fund Tokenization
On November 21, ISDA responded to the Financial Conduct Authority’s (FCA) consultation paper CP25/28 on progressing fund tokenization. In the response, ISDA focuses on the use of tokenized assets as both cleared and non-cleared derivatives collateral. Tokenization presents a significant...
ISDA Requests FASB to Consider ASC 815
On November 19, ISDA submitted a request to the Emerging Issues Task Force (EITF) of the Financial Accounting Standards Board (FASB) to clarify whether FASB Accounting Standards Codification (ASC) 815 does not prohibit using the spot method to assess hedge...
ISDA Response to CFTC Tokenized Collateral and Stablecoin Initiative
ISDA has responded to the CFTC’s Request for Input on the Tokenized Collateral and Stablecoin Initiative, offering perspectives on how tokenization and GENIUS Act–compliant payment stablecoins might contribute to more efficient and resilient collateral practices in derivatives markets. The letter...